Navigation Links
Palpable breast cancers are more common in women not undergoing annual mammography
Date:3/15/2010

CHICAGO (March 15, 2010) New research findings published in the March issue of the Journal of the American College of Surgeons indicate that some breast cancers continue to be detected as a palpable lump rather than being found through mammographic screening. Patients who presented with palpable tumors those detected as a result of breast complaint or during examination had larger tumors and were at a more advanced stage at diagnosis. The women who underwent yearly mammographic screening had the lowest rate of palpable presentation, in keeping with the reported benefit of mammography for early detection. Additionally, the data suggested that clinical breast examination (CBE) and breast self-examination should continue to play a role in detecting breast cancer.

Breast cancer is the second leading cause of death among women in the United States. The new breast cancer screening recommendations published in November 2009 by the U.S. Preventative Services Task Force (USPSTF) have been controversial because they now recommend against routine mammography screening for most women aged 40 to 49 years old. Additionally, the USPSTF concluded that current evidence is insufficient to assess the additional benefits and harms of CBE, beyond screening mammography in women 40 years or older, and recommended against teaching breast self-examination.

According to study investigator Amy C. Degnim, MD, FACS, associate professor of surgery, Mayo Clinic, Rochester, MN, a study by the Commission on Cancer in the 1990s showed that the percentage of breast cancer patients presenting with palpable masses decreased from 70 percent in 1983 to 44 percent in 1990. This decrease was most likely due to the increasing use of screening mammography, which aims to detect breast cancers before they are palpable. Little data has been published on the subject since 1990.

"We were a little surprised to find that the percentage of women with breast cancer who pre
'/>"/>

Contact: Sally Garneski
pressinquiry@facs.org
312-202-5409
Weber Shandwick Worldwide
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Mammography plus sonography can help rule out breast cancer in patients with palpable lesions
2. Reasonable alternative to invasive biopsy of palpable breast lesions with benign imaging features identified
3. Survival differences by race most apparent in advanced stages of breast cancer
4. MRI finds breast cancer before it becomes dangerous
5. Pathway links inflammation, angiogenesis and breast cancer
6. Drop in breast cancer incidence linked to hormone use, not mammograms
7. Breast cancer prevention practices vary across Canada
8. Eating junk food whilst pregnant and breastfeeding may lead to obese offspring
9. Acrylamide Wont Raise Breast Cancer Risk
10. New link between estrogen and breast cancer
11. Hypnosis Eases Pain of Breast Cancer Surgery
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... Padre Murphy's and Owner Tom Boyle in Glendale, ... Health Alliance (PPHA). The PPHA's passion for others' well-being ... NFL greats, treated for obstructive sleep apnea (OSA) has propelled ... cause in the valley. The most recent plans for an ...
(Date:1/22/2015)... January 23, 2015 AngelWeddingDress, the premier ... 2015 maternity wedding dresses. View website of ... looking for maternity wedding dresses online for a bridal ... with high quality for them. Its maternity wedding dresses ...
(Date:1/22/2015)... Autocarinsurancebest.com has released a new blog post explaining ... policy . , Auto insurance quotes help many drivers ... longer necessary to call an agent or visit an agency ... a single website: http://autocarinsurancebest.com/ . , Every business who ...
(Date:1/22/2015)... (PRWEB) January 22, 2015 Yesterday, ... Bonilla (D-Concord) and Kristin Olsen (R-Modesto) were honored ... leadership in advancing biotechnology, biomedical science, medical device ... Olsen each received the “2014 Life Sciences Champion” ...
(Date:1/22/2015)... (PRWEB) January 22, 2015 EBSCO Information ... (AMA) are expanding their relationship in an effort to further ... the world. While EBSCO has long made AMA journals available ... sales agent for The JAMA Network. , Long ...
Breaking Medicine News(10 mins):Health News:Padre Murphy's Holds NFL Retired Players Association Party Star Studded Event With Bud Light and Pro Player Health Alliance Sponsoring 2Health News:Padre Murphy's Holds NFL Retired Players Association Party Star Studded Event With Bud Light and Pro Player Health Alliance Sponsoring 3Health News:AngelWeddingDress Has Recently Released Its Collection Of 2015 Maternity Wedding Dresses 2Health News:Commercial Auto Insurance Provides Several Important Features! 2Health News:California Biomedical Community Honors Senator Holly Mitchell, Assemblymembers Susan Bonilla & Kristin Olsen 2Health News:California Biomedical Community Honors Senator Holly Mitchell, Assemblymembers Susan Bonilla & Kristin Olsen 3Health News:EBSCO Expands Partnership with the American Medical Association 2Health News:EBSCO Expands Partnership with the American Medical Association 3Health News:EBSCO Expands Partnership with the American Medical Association 4
... mind,s reward centers are less enthused, brain scans find , ... you see your paycheck may have a lot to do ... by researchers at the University of Bonn in Germany. , ... male volunteers divided into pairs. Each pair, in adjoining brain ...
... with a devastating brain injury that has wiped out ... to understand other peoples feelings and intentions, according to ... the Baycrest Centre for Aging and the Brain, and ... The study, published in the Nov. 23, 2007 issue ...
... midday sleepiness, experts say, , , THURSDAY, Nov. 22 (HealthDay ... the Thanksgiving feast aren,t rare, and experts say a ... holiday. , It may have to do with the ... -- a chemical known to promote sleepiness, said Donna ...
... on the future treatment of breast cancer have been identified ... published in the online open access journal Breast Cancer Research ... priorities. , A team led by Professor Mitch Dowsett, ... based in London and Surrey, together with colleagues from the ...
... Health Company,(Amex: FHC ) today announced that it ... Analyst Conference on Wednesday, November 28,2007 at the Princeton ... 5th and,6th). The Company,s CEO, O.B. Parrish, and its ... a.m. Eastern Time (EST)., A "live" webcast of ...
... more ozone, and more strain on hearts, researchers say ... and high ozone levels work together to boost death ... They believe that global warming -- which brings more ... number of people who die of cardiovascular events. , ...
Cached Medicine News:Health News:People with rare type of memory loss still sensitive to others, study shows 2Health News:People with rare type of memory loss still sensitive to others, study shows 3Health News:There's More Than Turkey Behind Holiday Yawns 2Health News:Found in translation: Prioritizing research questions in breast cancer 2Health News:The Female Health Company to Present at Wall Street Analyst Forum Wednesday, November 28, 2007 2Health News:Global Warming May Trigger Rise in Heart Deaths 2Health News:Global Warming May Trigger Rise in Heart Deaths 3
(Date:1/23/2015)... JUNCTION, N.J. , Jan. 23, 2015  CytoSorbents ... company commercializing its CytoSorb® extracorporeal cytokine adsorber to ... patients, announced the receipt of $385,642, net of ... participant of the Technology Business Tax Certificate Transfer ...
(Date:1/22/2015)...  ViewRay™, a privately held medical device company, announced today ... with ITOCHU Corporation (Tokyo Stock Exchange TYO: 8001) to ... of cancer in Japan . ViewRay,s ... and only MRI-guided radiation therapy system that images and ...
(Date:1/22/2015)... 22, 2015  Amgen (NASDAQ: AMGN ) today announced that ... results on Tuesday, Jan. 27, 2015, after the close of the ... call with the investment community at 2 p.m. PT. Participating in ... chairman and chief executive officer, and other members of Amgen,s senior ...
Breaking Medicine Technology:CytoSorbents Receives $385,000 in Non-Dilutive Funding from the New Jersey Technology Business Tax Certificate Transfer Program 2CytoSorbents Receives $385,000 in Non-Dilutive Funding from the New Jersey Technology Business Tax Certificate Transfer Program 3ITOCHU Named the Exclusive Distributor for ViewRay's MRI-Guided Radiation Therapy System in Japan 2Amgen Announces Webcast of 2014 Fourth Quarter and Full Year Financial Results 2
... Suggests that Adding Singulair to Advair Offers no Additional ... Improvement in ... TORONTO, May 18 /PRNewswire-FirstCall/,-- Patients with both asthma and ... when treated with Advair,Diskus(R) (fluticasone propionate and salmeterol inhalation ...
... ASCO Annual Meeting Will Further Demonstrate, the ... CAMBRIDGE, Mass., May 16 Millennium Pharmaceuticals,The Takeda ... studies are scheduled to be featured at the 2008 ... Illinois, May 30 -,June 3, 2008. The data will ...
Cached Medicine Technology:Patients With Asthma and Seasonal Allergies Respond Better to Advair(R) for Their Asthma Than Singulair(TM) 2Patients With Asthma and Seasonal Allergies Respond Better to Advair(R) for Their Asthma Than Singulair(TM) 3New Data Support High Complete Remission Rates With VELCADE(R) (Bortezomib) for Injection Based Therapies in Patients With Newly Diagnosed Multiple Myeloma 2New Data Support High Complete Remission Rates With VELCADE(R) (Bortezomib) for Injection Based Therapies in Patients With Newly Diagnosed Multiple Myeloma 3New Data Support High Complete Remission Rates With VELCADE(R) (Bortezomib) for Injection Based Therapies in Patients With Newly Diagnosed Multiple Myeloma 4New Data Support High Complete Remission Rates With VELCADE(R) (Bortezomib) for Injection Based Therapies in Patients With Newly Diagnosed Multiple Myeloma 5New Data Support High Complete Remission Rates With VELCADE(R) (Bortezomib) for Injection Based Therapies in Patients With Newly Diagnosed Multiple Myeloma 6New Data Support High Complete Remission Rates With VELCADE(R) (Bortezomib) for Injection Based Therapies in Patients With Newly Diagnosed Multiple Myeloma 7New Data Support High Complete Remission Rates With VELCADE(R) (Bortezomib) for Injection Based Therapies in Patients With Newly Diagnosed Multiple Myeloma 8
... Respiratory Products, ,Westmed designs, manufacturers and ... and Respiratory professionals. Our mission is to ... clinician's ability to deliver quality medical care ... line. , ,Our web site is ...
... nebulizer achieves optimum lung penetration for maximum ... is 1.04-1.10 µ at 6-8 LPM. Latex-free ... ,As the world leader in airway ... assurance of proven technology by offering top ...
... Most practitioners consider the HOPE nebulizer the ... have been made to put everything together in ... The result is our #11320 Adult HOPE Kit ... corrugated tubing and pediatric aerosol mask all in ...
... Portex® medication nebulizers offer a spill-proof design ... to a 45° angle. All medical nebulizers ... wide variety of configurations are available., ... , ,Portex® medication nebulizers feature consistently ...
Medicine Products: